Archived on: September 1, 2011. This document may contain dated information. It remains available to provide access to historical materials.
This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.
Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.
Figure 1. New England High Intensity Drug Trafficking Area
Figure 2. Greatest Drug Threat to the New England HIDTA Region as Reported by State and Local Law Enforcement Agencies, by Number of Respondents
Figure 3. Drug-Related Treatment Admissions to Publicly Funded Facilities in New England, 2004-2008
Figure 4. Number of Suspicious Activity Reports Filed in New England, by Type, 2004-2008
Drug Seizures in the New England HIDTA Region, 2009
Table 2. Cannabis Plants Eradicated at Indoor and Outdoor Cultivation Sites in the New England HIDTA Region, 2005-2009
Table 3. Drug-Related Deaths in New England States
Map A1. Opioid Deaths in
Connecticut, by County, 2009
Map A2. Opioid Deaths in Massachusetts, by County, 2007
Map A3. Opioid Deaths in New Hampshire, by County, 2009
Map A4. Opioid Deaths in Vermont, by County, 2009
Opioid abuse (particularly the abuse of South American (SA) heroin and diverted controlled prescription opioids) is the primary drug concern in the New England High Intensity Drug Trafficking Area (NE HIDTA) region. Opioid abuse is associated with high levels of violent crime and property crime and accounts for 70 percent of all illicit drug-related treatment admissions and the majority of poison center hotline calls, hospital visits, and drug-related deaths in the region.
The following are significant strategic drug threat developments in the NE HIDTA region:
To Top To Contents
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622
Tel. (814) 532-4601
FAX (814) 532-4690
Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000
Telephone: (202) 532-4040
FAX (202) 514-4252
Questions and comments may be directed to New England/New York/New Jersey Unit, Regional Threat Analysis Branch through NDIC.Contacts@usdoj.gov.
End of page.